Saturday 17 October 2026 Export RADX’s income statement to Excel — free account

Radiopharm Theranostics Limited - Sponsored ADR

RADX Healthcare Biotechnology

Radiopharm Theranostics Limited - Sponsored ADR’s revenue for fiscal 2026 (year ended June 2026) was $1.9 million, down 20.2% from fiscal 2025.

1.03 0.05 −4.63%

Follow RADX

Alert me

Market cap: $17.0M
P/E: —
Fwd P/E: —
Dividend yield: —
F-score: 3/9
Altman Z: −6.65
Beneish M: −2.62
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+1 more TTM period Free account	—	—	—	0.00%
ROA Full definition →		—	—	—	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		—	—	0.00	0.00
Free Cash Flow Full definition →		—	—	(68.16)	(88.91)
Other line items
Cash ROIC Full definition →		0.00%	0.00%	(122.94%)	(495.06%)
Accounts Receivable Turnover Full definition →		—	—	—	0.00
Accounts Payable Turnover Full definition →		—	—	—	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		—	—	0.00	0.00
Depreciation/Fixed assets Full definition →		0.00	—	0.00	—
Operating CF per Share Full definition →		—	—	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 16 Oct 2026